Dopamine release and molecular modeling study of some coumarin derivatives

Neurochemistry International

Volumn 59, Issue 6, 2011, Pages 906-912

  Abdelhafez, Omaima M ^a   Amin, Kamelia M ^b   Ali, Hamed I ^c   Maher, Timothy J ^d   Batran, Rasha Z ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c Helwan University   (Egypt)

^d BOSTON UNIVERSITY   (United States)

Author keywords

Coumarin; Dopamine release; Molecular modeling

Indexed keywords

1 PHENYL 5 (PYRIDIN 3 YL) 1H PYRAZOL 3 YL) 4 HYDROXY 2H CHROMEN 2 ONE; 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 5 (3,4,5 TRIMETHOXYPHENYL) N PHENYL PYRAZOLE 1 CARBOTHIOAMIDE; 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) 5 (4 METHOXY PHENYL) N PHENYL PYRAZOLE 1 CARBOTHIOAMIDE; 3 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL) N PHENYL 5 (PYRIDIN 3 YL)PYRAZOLE 1 CARBOTHIOAMIDE; 3 (6 ARYL 1,2,5,6 TETRAHYDRO 2 THIOXOPYRIMIDIN 4 YL) 4 HYDROXY 2H CHROMEN 2 ONE; 4 ARYL 2 AMINO 6 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL)PYRIDIN 3 CARBONITRILE; 4 ARYL 2 OXO 6 (4 HYDROXY 2 OXO 2H CHROMEN 3 YL)PYRIDIN 3 CARBONITRILE; AMPHETAMINE; COUMARIN DERIVATIVE; DOPAMINE; PYRAZOL 3 YL 4 HYDROXYCOUMARIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG BINDING; DRUG INHIBITION; DRUG STRUCTURE; ENERGY; MOLECULAR MODEL; PRIORITY JOURNAL;

4-HYDROXYCOUMARINS; ANIMALS; DOPAMINE; ENERGY METABOLISM; HUMANS; MODELS, CHEMICAL; MODELS, MOLECULAR; NEURONS; PC12 CELLS; RATS; STEREOISOMERISM;

EID: 80155130523     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.08.004     Document Type: Article

References (21)

1. O.M. Abdelhafez, K.M. Amin, R.Z. Batran, T.J. Maher, S.A. Nada, and S. Sethumadhavan Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives Bioorg. Med. Chem. 18 2010 3371
2. N.J. Bach, E.C. Kornfeld, N.D. Jones, M.O. Chaney, M.O.D.E. Dorman, J.W. Paschal, J.A. Clemens, and E.B. Smalstig Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists. J.Med.Chem. 23 5 1980 4
3. L. Esser, C.R. Wang, M. Hosaka, C.S. Smagula, T.C. Sudhof, and J. Deisenhofer Synapsin I is structurally similar to ATP-utilizing enzymes EMBO J. 17 1998 977984
4. Filippakopoulos, P., Rellos, P., Niesen, F., Burgess, N., Bullock, A., Berridge, G., Pike, A.C.W., Ugochukwu, E., Pilka, E.S., von Delft, F., Arrowsmith, C.H., Edwards, A.M., Weigelt, J., Knapp, S. Crystal structure of human calcium/calmodulin-dependent protein kinase iib isoform 1 (CAMK2B)", Through Protein Data Bank web site: http: //www. rcsb.org / pdb/ explore/ explore.do structure Id=3BHH. To be published.
5. C.T. Giambalvo Protein kinase C and dopamine transport-1. Effects of amphetamine in vivo. Neuropharmacology 31 1992 1201
6. F. Gierski, C. Peretti, and A. Ergis Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluency Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 1 2007 262
7. S.A. Glase, A.E. Corbin, T.A. Pugsley, T.G. Heffner, and L.D. Wise Synthesis and dopaminergic activity of pyridine analogs of 5-hydroxy-2-(di-n- propylamino)tetralin J. Med. Chem. 38 16 1995 3132
8. J.J.H. Hens, M. DeWit, F. Boomsma, M. Mercken, A.B. Oestreicher, W.H. Gispen, and P.N.E. De Graan N-terminal-specific anti-B-50 (GAP-43) antibodies inhibit Ca21-induced noradrenaline release, B-50 phosphorylation and dephosphorylation, and calmodulin binding J. Neurochem. 64 1995 1127
9. S. Iwata, G.H.K. Hewlett, S.T. Ferrell, A.J. Czernik, K.F. Meiri, and M.E. Gnegy Increased in vivo phosphorylation of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine J. Pharm. Exp. Therap. 278 1996 1428
10. S. Iwata, G.H.K. Hewlett, and M.E. Gnegy Amphetamine increases the phosphorylation of neuromodulin and synapsin i in rat striatal synaptosomes Synapse 26 1997 281
11. L. Kantor, G.H.K. Hewlett, and M.E. Gnegy Enhanced amphetamine- and k1-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles J Neuroscience 19 1999 3801
12. K.S. Kim, D.H. Park, T.C. Wessel Song, B.J.A. Wager, and T.H. Joh A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression Proc. Natl. Acad. Sci. USA 90 1993 3471
13. N.Y. Liang, and C.O. Rutledge Comparison of the release of [3H] dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine Biochem. Pharmacol. 31 1982 983
14. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, and A.J. Olson Automated Docking Using a Lamarckian Genetic Algorithm and and Empirical Binding Free Energy Function J. Comput. Chem. 19 1998 16391662
15. G.M. Morris, R. Huey, W. Lindstrom, M.F. Sanner, R.K. Belew, D.S. Goodsell, and A.J. Olson AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility J. Comp. Chem. 30 2009 2785
16. Q. Shen, Q. Peng, J. Shao, X. Liu, Z. Huang, X. Pu, L. Ma, Y.-M. Li, A.S.C. Chan, and L. Gu Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors Eur.J. Med. Chem. 40 2005 1307
17. R. Wang, Y. Wang, and S. Lu Comparative evaluation of 11 scoring functions for molecular docking J. Med. Chem. 46 2003 2287
18. Y.J. Yang, H.J. Lee, D.H. Choi, H.S. Huang, S.C. Lim, and N.K. Lee Effect of scoparone on neurite outgrowth in PC12 cells Neurosci.Lett. 440 2008 14
19. Y.J. Yang, H.J. Lee, H.S. Huang, B.K. Lee, H.S. Choi, S.C. Lim, C.K. Lee, and M.K. Lee Effects of scoparone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells J.Neurosci. Res. 87 2009 1929
20. Y.J. Yang, H.J. Lee, B.K. Lee, S.C. Lim, C.K. Lee, and M.K. Lee Effects of scoparone on dopamine release in PC12 cells Fitoterapia 81 2010 497
21. X. Zhou, X.-B. Wang, T. Wang, and L.-Y. Kong Design, synthesis, and acetyl -cholinesterase inhibitory activity of novel coumarin analogues Bioorg. Med.Chem. 16 2008 8011